市場調査レポート
商品コード
1481942

アジア太平洋地域の魚類ワクチン:2030年までの市場予測 - 地域分析 - ワクチンタイプ、用途、投与経路、魚種別

Asia Pacific Fish Vaccines Market Forecast to 2030 - Regional Analysis - by Vaccine Type, Application, Route of Administration, and Species

表紙:アジア太平洋地域の魚類ワクチン:2030年までの市場予測 - 地域分析 - ワクチンタイプ、用途、投与経路、魚種別

出版日
ページ情報
英文 100 Pages
納期
即納可能
アジア太平洋地域の魚類ワクチン:2030年までの市場予測 - 地域分析 - ワクチンタイプ、用途、投与経路、魚種別
出版日: 2024年02月28日
発行: The Insight Partners
ページ情報: 英文 100 Pages
納期: 即納可能
GIIご利用のメリット
  • 全表示

  • 概要
  • 図表
  • 目次
概要

アジア太平洋地域の魚類ワクチン市場は、2022年に4,687万米ドルと評価され、2030年には9,415万米ドルに達すると予測され、2022年から2030年までのCAGRは9.1%で成長すると予測されています。

新規魚類ワクチンの市場開拓がアジア太平洋地域の魚類ワクチン市場を活性化

寄生虫、ウイルス、バクテリアによる病気の発生は、数十年にわたり世界の養殖産業の発展を遅らせてきました。人間の健康に有害であることはさておき、新興の疾病は水産動物に大きな影響を及ぼしています。従来のワクチンには限界や欠点があり、キメラマルチエピトープワクチンのような新規の先端ワクチンの開発需要が高まっています。水生ワクチンの基礎・応用研究分野では、科学技術の進歩により新たな道が開かれています。新しい技術、アプローチ、戦略を用いて、より高品質で効率的な新規水生ワクチンを創製する努力がなされてきました。

利用可能なバイオインフォマティクスツールやイムノプロテオミクスやゲノミクスの最新の知識を用いることで、研究者は免疫細胞が認識できる潜在的な標的エピトープを同定することができます。さらに、全ゲノム配列決定のような技術のコストが低下し続けるにつれて、種特異的ワクチン開発の道が開かれます。これにより、新規ワクチン開発への投資が活発化する可能性が高いです。2021年、インドでは中央汽水養殖研究所(ICAR)がウイルス性神経壊死症(VNN)に対する組み換えワクチンを発売しました。

このように、投与プロセスを強化した効果的な粘膜ワクチンの開発は、新規ワクチン開発を加速させ、地中海諸国の養殖事業を後押しし、魚類ワクチン接種プロセスを定期化させることが期待されます。したがって、新規魚類ワクチンの開拓は、市場成長の大きな機会を生み出す可能性が高いです。

アジア太平洋地域の魚類ワクチン市場概要

アジア太平洋地域の魚類ワクチン市場は、中国、日本、インド、韓国、オーストラリア、その他アジア太平洋地域に区分されます。これらの国々における市場成長は、同地域における養殖セクターの台頭と政府の積極的な取り組みに起因しています。さらに、市場プレーヤーが実施する拡大戦略や製品上市戦略は、同地域の魚類ワクチン市場の成長に寄与すると予想されます。日本における商業的養殖生産は、第2次世界大戦の終結以来劇的に発展し、漁業部門で重要な位置を占めています。年間漁業統計の養殖の項には60種以上が含まれています。このうち主なものは、ノリ、ヤエソホタテ、カキ、カンパチ、アカムツ、シウマイなどです。しかし、水産物の国内需要は今後10年で減少し、養殖の生産量も国内需要に依存したままでは減少します。日本におけるこうした需要の減少は、日本の人口が減少し、食生活が肉へとシフトしているためです。

アジア太平洋地域の魚類ワクチン市場の収益と2030年までの予測(金額)

アジア太平洋地域の魚類ワクチン市場セグメンテーション

アジア太平洋地域の魚類ワクチン市場は、ワクチンタイプ、用途、投与経路、魚種、国によって区分されます。

ワクチンタイプに基づき、アジア太平洋地域の魚類ワクチン市場は不活化ワクチン、弱毒生ワクチン、サブユニットワクチン、組み換えベクターワクチン、その他に区分されます。不活化ワクチン分野は2022年に最大の市場シェアを占めました。

用途別では、アジア太平洋地域の魚類ワクチン市場は細菌感染、ウイルス感染、寄生虫に区分されます。細菌感染セグメントが2022年に最大の市場シェアを占めました。

投与経路に基づき、アジア太平洋地域の魚類ワクチン市場は注射ワクチン、浸漬ワクチン、経口ワクチンに区分されます。注射ワクチンセグメントが2022年に最大の市場シェアを占めました。

魚種に基づき、アジア太平洋地域の魚類ワクチン市場はサケ、マス、ティラピア、その他に区分されます。サケセグメントが2022年に最大の市場シェアを占めました。

国別では、アジア太平洋地域の魚類ワクチン市場は中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域に区分されます。2022年のアジア太平洋地域の魚類ワクチン市場シェアは日本が独占しました。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • アジア太平洋地域の魚類ワクチン市場

第3章 調査手法

  • 対象範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋地域の魚類ワクチン市場:主要産業力学

  • 市場促進要因
    • 水産養殖産業発展への政府の取り組み
    • 水産動物由来食品への需要急増
  • 市場抑制要因
    • ワクチン認可のための厳しい規制
  • 市場機会
    • 新規魚類ワクチンの開発
  • 今後の動向
    • 魚類ワクチンの技術的進歩
  • 影響分析

第5章 魚類ワクチン市場:アジア太平洋地域市場分析

  • 魚類ワクチンの市場収益、2022年~2030年

第6章 アジア太平洋地域の魚類ワクチン市場 - 収益と2030年までの予測:ワクチンタイプ別

  • 市場収益シェア、2022年および2030年
  • 不活化ワクチン
  • 生ワクチン
  • サブユニットワクチン
  • 組み換えベクターワクチン
  • その他

第7章 アジア太平洋地域の魚類ワクチン市場 - 収益と2030年までの予測:用途別

  • 市場収益シェア、2022年および2030年
  • 細菌感染
  • ウイルス感染
  • 寄生虫感染

第8章 アジア太平洋地域の魚類ワクチン市場 - 収益と2030年までの予測:投与経路別

  • 市場収益シェア、2022年および2030年
  • 注射ワクチン
  • 浸漬ワクチン
  • 経口ワクチン

第9章 アジア太平洋地域の魚類ワクチン市場 - 収益と2030年までの予測:魚種別

  • 市場収益シェア、2022年および2030年
  • サーモン
  • マス
  • ティラピア
  • その他

第10章 アジア太平洋地域の魚類ワクチン市場:国別分析

  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域

第11章 魚類ワクチン市場- 業界情勢

  • 魚類ワクチン市場の成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • Zoetis Inc
  • Merck & Co Inc
  • HIPRA SA
  • Phibro Animal Health Corp
  • Vaxxinova International BV
  • Kyoto Biken Laboratories Inc
  • Elanco Animal Health Inc
  • Nisseiken Co Ltd
  • KBNP Inc
  • Choong Ang Vaccine Laboratory
  • Indian Immunologicals Ltd

第13章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Fish Vaccine Market Segmentation
  • Table 2. Worldwide Fish Production and Consumption in 2022
  • Table 3. Major Bacterial Diseases in Fish
  • Table 4. Major Viral Diseases in Fish
  • Table 5. Major Parasitic Diseases in Fish
  • Table 6. Atlantic Salmon Production 2020
  • Table 7. China Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 8. China Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 9. China Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 10. China Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 11. Japan Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 12. Japan Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 13. Japan Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 14. Japan Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 15. India Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 16. India Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 17. India Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 18. India Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 19. Australia Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 20. Australia Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 21. Australia Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 22. Australia Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 23. South Korea Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 24. South Korea Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 25. South Korea Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 26. South Korea Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 27. Rest of Asia Pacific Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 28. Rest of Asia Pacific Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 29. Rest of Asia Pacific Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 30. Rest of Asia Pacific Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 31. Recent Inorganic Growth Strategies in the Fish Vaccine Market
  • Table 32. Recent Organic Growth Strategies in Fish Vaccine Market
  • Table 33. Glossary of Terms, Asia Pacific Fish Vaccine Market

List Of Figures

  • Figure 1. Asia Pacific Fish Vaccine Market Segmentation, By Country
  • Figure 2. Asia Pacific Fish Vaccine Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Fish Vaccine Market Revenue (US$ Th), 2022 - 2030
  • Figure 5. Asia Pacific Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
  • Figure 6. Inactivated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 7. Live Attenuated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 8. Subunit Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 9. Recombinant Vector Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 10. Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 11. Asia Pacific Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
  • Figure 12. Bacterial Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 13. Viral Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 14. Parasitic: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 15. Asia Pacific Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
  • Figure 16. Injected: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 17. Immersion Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 18. Oral Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 19. Fish Vaccine Market Revenue Share, Species, 2022 & 2030 (%)
  • Figure 20. Salmon: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 21. Trout: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 22. Tilapia: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 23. Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 24. Asia Pacific Fish Vaccine Market, by Key Country - Revenue, 2022 (US$ Thousand)
  • Figure 25. Asia Pacific Fish Vaccine Market, By Key Countries, 2022 and 2030 (%)
  • Figure 26. China Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 27. Japan Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 28. India Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 29. Australia Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 30. South Korea Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 31. Rest of Asia Pacific Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 32. Growth Strategies in Fish Vaccine Market
目次
Product Code: BMIRE00029704

The Asia Pacific fish vaccines market was valued at US$ 46.87 million in 2022 and is expected to reach US$ 94.15 million by 2030; it is estimated to grow at a CAGR of 9.1% from 2022 to 2030.

Development of Novel Fish Vaccine Fuels the Asia Pacific Fish Vaccine Market

Emergence of disease outbreak caused by parasites, viruses, and bacteria have slowed down the evolution of the global aquaculture industry for several decades. Aside from being harmful to human health, emerging diseases have a significant impact on aquatic animals. Traditional vaccines have limitations and drawbacks, which bolsters the demand for the development of novel advanced vaccines such as chimeric multiepitope vaccines. Newer avenues in the basic and applied research fields of aquatic vaccines have been opened up by scientific and technological advancements. An effort has been made to create novel aquatic vaccines with higher quality and efficiency using new technologies, approaches, and strategies.

Using the available bioinformatics tools and current knowledge of immunoproteomics and genomics, researchers can identify potential targeted epitopes that immune cells can recognize. Further, as the cost of techniques such as whole genome sequencing continues to decline, it opens the way for species-specific vaccine development. This is likely to boost investments in developing new vaccines. In 2021, the Central Institute of Brackishwater Aquaculture (ICAR) launched a recombinant vaccine against viral nervous necrosis (VNN) in India.

Thus, the development of an effective mucosal vaccine with strengthening the administration process is expected to accelerate the novel vaccine development, which would boost the aquaculture businesses in Mediterranean countries to regularize fish vaccination processes. Hence, development of novel fish vaccines is likely creating significant opportunity for market growth.

Asia Pacific Fish Vaccines Market Overview

The Asia Pacific fish vaccines market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The market growth in these countries is attributed to the rising aquaculture sector in the region and favorable government initiatives. Moreover, expansion and product launch strategies implemented by market players are expected to contribute to the growth of the fish vaccines market in the region. Commercial aquaculture production in Japan has developed dramatically since the end of the 2nd World War and occupies an important place in the fisheries sector. More than 60 species are included in the aquaculture section of the annual fisheries statistics. Of these, the main species are Nori, yesso scallop, oyster, Japanese amberjack, red seabream, and sea mustard. However, domestic demand for seafood products will decline in the next decade, and the production of aquaculture will decline if it remains dependent on domestic demand. This decline in demand in Japan is because Japan's population is dropping, and their diets are shifting toward meat.

Asia Pacific Fish Vaccines Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Fish Vaccines Market Segmentation

The Asia Pacific fish vaccines market is segmented based on vaccine type, application, route of administration, species, and country.

Based on vaccine type, the Asia Pacific fish vaccines market is segmented into inactivated vaccines, live attenuated vaccines, subunit vaccines, recombinant vector vaccine, and others. The inactivated vaccines segment held the largest market share in 2022.

Based on application, the Asia Pacific fish vaccines market is segmented into bacterial infection, viral infection, and parasitic. The bacterial infection segment held the largest market share in 2022.

Based on route of administration, the Asia Pacific fish vaccines market is segmented into injection vaccine, immersion vaccine, and oral vaccine. The injection vaccine segment held the largest market share in 2022.

Based on species, the Asia Pacific fish vaccines market is segmented into salmon, trout, tilapia, and others. The salmon segment held the largest market share in 2022.

Based on country, the Asia Pacific fish vaccines market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Japan dominated the Asia Pacific fish vaccines market share in 2022.

Choong Ang Vaccine Laboratories Co.; Elanco Animal Health Inc; Hipra SA; INDIAN IMMUNOLOGICALS LTD; KBNP Inc.; Kyoto Biken Laboratories; Merck & Co Inc.; Nisseiken Co., Ltd.; Phibro Animal Health Corp; Vaxxinova International BV; and Zoetis Inc. are some of the leading companies operating in the Asia Pacific fish vaccines market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Asia Pacific Fish Vaccine Market

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Fish Vaccine Market - Key Industry Dynamics

  • 4.1 Market Drivers:
    • 4.1.1 Government Initiatives to Develop Aquaculture Industry
    • 4.1.2 Surging Demand for Aquatic Animal-Derived Food Products
  • 4.2 Market Restraints
    • 4.2.1 Stringent Regulations for Approval of Vaccine
  • 4.3 Market Opportunities
    • 4.3.1 Development of Novel Fish Vaccine
  • 4.4 Future Trends
    • 4.4.1 Technological Advancements in Fish Vaccine
  • 4.5 Impact Analysis:

5. Fish Vaccine Market - Asia Pacific Market Analysis

  • 5.1 Fish Vaccine Market Revenue (US$ Th), 2022 - 2030

6. Asia Pacific Fish Vaccine Market - Revenue and Forecast to 2030 - by Vaccine Type

  • 6.1 Overview
  • 6.2 Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
  • 6.3 Inactivated Vaccines
    • 6.3.1 Overview
    • 6.3.2 Inactivated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.4 Live Attenuated Vaccines
    • 6.4.1 Overview
    • 6.4.2 Live Attenuated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.5 Subunit Vaccines
    • 6.5.1 Overview
    • 6.5.2 Subunit Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.6 Recombinant Vector Vaccine
    • 6.6.1 Overview
    • 6.6.2 Recombinant Vector Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.7 Others
    • 6.7.1 Overview
    • 6.7.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

7. Asia Pacific Fish Vaccine Market - Revenue and Forecast to 2030 - by Application

  • 7.1 Overview
  • 7.2 Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
  • 7.3 Bacterial Infection
    • 7.3.1 Overview
    • 7.3.2 Bacterial Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 7.4 Viral Infection
    • 7.4.1 Overview
    • 7.4.2 Viral Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 7.5 Parasitic
    • 7.5.1 Overview
    • 7.5.2 Parasitic: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

8. Asia Pacific Fish Vaccine Market - Revenue and Forecast to 2030 - by Route of Administration

  • 8.1 Overview
  • 8.2 Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
  • 8.3 Injection vaccine
    • 8.3.1 Overview
    • 8.3.2 Injection vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 8.4 Immersion Vaccine
    • 8.4.1 Overview
    • 8.4.2 Immersion Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 8.5 Oral Vaccine
    • 8.5.1 Overview
    • 8.5.2 Oral Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

9. Asia Pacific Fish Vaccine Market - Revenue and Forecast to 2030 - by Species

  • 9.1 Overview
  • 9.2 Fish Vaccine Market Revenue Share, by Species, 2022 & 2030 (%)
  • 9.3 Salmon
    • 9.3.1 Overview
    • 9.3.2 Salmon: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 9.4 Trout
    • 9.4.1 Overview
    • 9.4.2 Trout: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 9.5 Tilapia
    • 9.5.1 Overview
    • 9.5.2 Tilapia: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

10. Asia Pacific Fish Vaccine Market - Country Analysis

  • 10.1 Asia Pacific Fish Vaccine Market, Revenue and Forecast to 2030
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific Fish Vaccine Market, by Country
      • 10.1.2.1 China
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 China Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.1.3 China: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.1.4 China: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.1.5 China: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.1.6 China: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
      • 10.1.2.2 Japan
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Japan Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.2.3 Japan: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.2.4 Japan: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.2.5 Japan: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.2.6 Japan: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
      • 10.1.2.3 India
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 India Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.3.3 India: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.3.4 India: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.3.5 India: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.3.6 India: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
      • 10.1.2.4 Australia
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 Australia Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.4.3 Australia: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.4.4 Australia: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.4.5 Australia: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.4.6 Australia: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
      • 10.1.2.5 South Korea
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 South Korea Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.5.3 South Korea: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.5.4 South Korea: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.5.5 South Korea: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.5.6 South Korea: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
      • 10.1.2.6 Rest of Asia Pacific
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Rest of Asia Pacific Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.6.3 Rest of Asia Pacific: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.6.4 Rest of Asia Pacific: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.6.5 Rest of Asia Pacific: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.6.6 Rest of Asia Pacific: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)

11. Fish Vaccine Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Fish Vaccine Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Zoetis Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Merck & Co Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 HIPRA SA
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Phibro Animal Health Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Vaxxinova International BV
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Kyoto Biken Laboratories Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Elanco Animal Health Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Nisseiken Co Ltd
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 KBNP Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Choong Ang Vaccine Laboratory
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Indian Immunologicals Ltd
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms